Comparative pharmacoepidemiological study of antihyperglycemic drugs utilization by patients with type 2 diabetes mellitus in Moscow

Código QR

Comparative pharmacoepidemiological study of antihyperglycemic drugs utilization by patients with type 2 diabetes mellitus in Moscow

Background. A pharmaco-epidemiological study comparing the dynamics of different anti-diabetic drugs in patients with type 2 diabetes mellitus (T2DM) in Russia was conducted using data from a diabetes registry.Objective. To assess and compare the frequency of the prescription of oral anti-diabetic m...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marina F. Kalashnikova, Dmitrii Y. Belousov, Maria A. Kantemirova, Mikhail B. Antsiferov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2016
Materias:	type 2 diabetes mellitus pharmacoepidemiology drug utilization hypoglycemic agents russian federation Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/09884a86f20b40cab8922856a4ed5ad9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pharmacoepidemiological and pharmacoeconomic analyses of the utilization of hypoglycaemic drugs in patients with type 2 diabetes mellitus in Moscow
por: Marina Fedorovna Kalashnikova, et al.
Publicado: (2015)

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
por: Ivan I. Dedov, et al.
Publicado: (2017)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2013)

Pharmacogenetics of hypoglycemic agents
por: Irina Vladimirovna Kononenko, et al.
Publicado: (2015)

Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
por: Ivan Ivanovich Dedov, et al.
Publicado: (2011)

Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2013)

Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013–2016)
por: Alexander Y. Mayorov, et al.
Publicado: (2018)

Analysis of epidemiological indices of type 2 diabetes mellitus in the adult population of Moscow
por: Marina Fedorovna Kalashnikova, et al.
Publicado: (2014)

Initiation and intensification of antihyperglycemic therapy in type 2 diabetes mellitus: Update of Russian Association of Endocrinologists expert consensus document (2015)
por: Ivan Ivanovich Dedov, et al.
Publicado: (2015)

The dynamics of the main epidemiological indicators among living in Moscow patients with diabetes mellitus (2013–2018)
por: Mikhail B. Antsiferov, et al.
Publicado: (2020)

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
por: Marina V. Shestakova, et al.
Publicado: (2017)

Eficacia de los hipoglicemiantes orales en el control metabólico de pacientes con diabetes mellitus gestacional
por: Valdés R,Enrique, et al.
Publicado: (2008)

The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)
por: Ivan I. Dedov, et al.
Publicado: (2016)

Vildagliptin and its role in the treatment of diabetes mellitus
por: Yury Shavkatovich Khalimov
Publicado: (2010)

Risk factors for diabetic autonomic cardiovascular neuropathy in children and adolescents with type 1 diabetes mellitus
por: Maria Rustemovna Shaidullina, et al.
Publicado: (2013)

XXV (88) Session of Russian Academy of Medical Sciences General Meeting, 7-9 December 2011, Moscow
por: Editorial team Diabetes Mellitus
Publicado: (2011)

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
por: Yury Ivanovich Suntsov
Publicado: (2012)

Evaluación del perfil de eficacia y seguridad de vildagliptina en vida real de pacientes chilenos con diabetes mellitus tipo 2
por: Godoy J,Gonzalo, et al.
Publicado: (2015)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
por: Gagik R. Galstyan, et al.
Publicado: (2017)

Diabetes Mellitus tipo 2 con tendencia a la cetosis: Caso clínico
por: Concha L,Luciana, et al.
Publicado: (2015)

Pis'mo v redaktsiyu zhurnala ?Sakharnyy diabet?. Analogi insulina - novyy etap v lechenii sakharnogo diabeta 2 tipa ili ? ?staryy drug luchshe novykh dvukh??
por: Mikhail Borisovich Antsiferov
Publicado: (2007)

Effect of oral antihyperglycemic drugs on purine metabolism
por: T. S. Panevin
Publicado: (2021)

5 Russian Diabetology Congress on May 23-26, 2010, Moscow
por: Editorial team Diabetes Mellitus
Publicado: (2010)

5 Russian diabetology congress, May 23-26, 2010 Moscow
por: Editorial team Diabetes Mellitus
Publicado: (2009)

Hypoglycemic therapy in patients on hemodialysis and peritoneal dialysis
por: Irina Arkad'evna Bondar', et al.
Publicado: (2010)

Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2010)

Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
por: Marina Sergeevna Michurova, et al.
Publicado: (2014)

Modern antihyperglycemic therapy: safety and efficacy of glimepiride
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2012)

Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapyin type 2 diabetes mellitus
por: Ivan Ivanovich Dedov, et al.
Publicado: (2011)

Diabetes type 2 diabetes in the elderly – solved and unsolved questions
por: Tat'jana Vladimirovna Saprina, et al.
Publicado: (2016)

Type 2 diabetes mellitus in elderly patients treated with endocrinologists in clinical practice
por: Elena V. Biryukova
Publicado: (2019)

Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
por: Marina Fedorovna Kalashnikova, et al.
Publicado: (2011)

Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021
por: I. I. Dedov, et al.
Publicado: (2021)

Antihyperglycemic therapy in patients with type 2 diabetes mellitus and ischaemic heart disease: management during acute period of myocardial infarction and interventional procedures
por: Olga Mikhailovna Smirnova, et al.
Publicado: (2012)

Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
por: I. V. Kononenko, et al.
Publicado: (2021)

Barriers for efficacious hypoglycemic therapy in clinical practice (results of the Dialogue study)
por: Irina Evgen'evna Sapozhnikova, et al.
Publicado: (2010)

Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
por: Ivan Ivanovich Dedov, et al.
Publicado: (2012)

Federal targeted programme 'Prevention and Management of Socially Significant Diseases (2007-2012)': results of the 'Diabetes mellitus' sub-programme
por: Ivan Ivanovich Dedov, et al.
Publicado: (2013)

Rezul'taty UKPDS i ikh znachenie v sovershenstvovanii spetsializirovannoy pomoshchi bol'nym diabetom
por: Mikhail Borisovich Antsiferov
Publicado: (1999)

Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010)